| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | neurexin family protein binding | 6.70e-06 | 16 | 47 | 3 | GO:0042043 | |
| GeneOntologyMolecularFunction | chloride ion binding | 6.70e-06 | 16 | 47 | 3 | GO:0031404 | |
| GeneOntologyMolecularFunction | tyrosine-ester sulfotransferase activity | 3.24e-05 | 4 | 47 | 2 | GO:0017067 | |
| GeneOntologyMolecularFunction | amine sulfotransferase activity | 3.24e-05 | 4 | 47 | 2 | GO:0047685 | |
| GeneOntologyMolecularFunction | flavonol 3-sulfotransferase activity | 5.40e-05 | 5 | 47 | 2 | GO:0047894 | |
| GeneOntologyMolecularFunction | steroid sulfotransferase activity | 1.13e-04 | 7 | 47 | 2 | GO:0050294 | |
| GeneOntologyMolecularFunction | sulfate binding | 1.93e-04 | 9 | 47 | 2 | GO:0043199 | |
| GeneOntologyMolecularFunction | aryl sulfotransferase activity | 2.41e-04 | 10 | 47 | 2 | GO:0004062 | |
| GeneOntologyMolecularFunction | 3'-phosphoadenosine 5'-phosphosulfate binding | 4.16e-04 | 13 | 47 | 2 | GO:0050656 | |
| GeneOntologyMolecularFunction | scaffold protein binding | 1.37e-03 | 93 | 47 | 3 | GO:0097110 | |
| GeneOntologyMolecularFunction | NAD+-protein poly-ADP-ribosyltransferase activity | 1.97e-03 | 28 | 47 | 2 | GO:0003950 | |
| GeneOntologyMolecularFunction | NAD+-protein ADP-ribosyltransferase activity | 2.26e-03 | 30 | 47 | 2 | GO:1990404 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on glycosyl bonds | 4.72e-03 | 144 | 47 | 3 | GO:0016798 | |
| GeneOntologyBiologicalProcess | presynaptic membrane assembly | 1.40e-06 | 10 | 48 | 3 | GO:0097105 | |
| GeneOntologyBiologicalProcess | postsynaptic membrane assembly | 1.93e-06 | 11 | 48 | 3 | GO:0097104 | |
| GeneOntologyBiologicalProcess | presynaptic membrane organization | 3.33e-06 | 13 | 48 | 3 | GO:0097090 | |
| GeneOntologyBiologicalProcess | neuron cell-cell adhesion | 6.48e-06 | 16 | 48 | 3 | GO:0007158 | |
| GeneOntologyBiologicalProcess | territorial aggressive behavior | 1.59e-05 | 3 | 48 | 2 | GO:0002124 | |
| GeneOntologyBiologicalProcess | vocalization behavior | 2.31e-05 | 24 | 48 | 3 | GO:0071625 | |
| GeneOntologyBiologicalProcess | male courtship behavior | 3.17e-05 | 4 | 48 | 2 | GO:0008049 | |
| GeneOntologyBiologicalProcess | 4-nitrophenol metabolic process | 5.28e-05 | 5 | 48 | 2 | GO:0018960 | |
| GeneOntologyBiologicalProcess | postsynapse assembly | 6.47e-05 | 93 | 48 | 4 | GO:0099068 | |
| GeneOntologyBiologicalProcess | courtship behavior | 1.11e-04 | 7 | 48 | 2 | GO:0007619 | |
| GeneOntologyBiologicalProcess | brainstem development | 1.47e-04 | 8 | 48 | 2 | GO:0003360 | |
| GeneOntologyBiologicalProcess | regulation of stress-activated protein kinase signaling cascade | 1.90e-04 | 48 | 48 | 3 | GO:0070302 | |
| GeneOntologyBiologicalProcess | protein poly-ADP-ribosylation | 2.88e-04 | 11 | 48 | 2 | GO:0070212 | |
| GeneOntologyBiologicalProcess | postsynaptic membrane organization | 3.01e-04 | 56 | 48 | 3 | GO:0001941 | |
| GeneOntologyBiologicalProcess | mating behavior | 3.17e-04 | 57 | 48 | 3 | GO:0007617 | |
| GeneOntologyBiologicalProcess | presynapse assembly | 3.69e-04 | 60 | 48 | 3 | GO:0099054 | |
| GeneOntologyBiologicalProcess | aggressive behavior | 4.07e-04 | 13 | 48 | 2 | GO:0002118 | |
| GeneOntologyBiologicalProcess | membrane assembly | 4.46e-04 | 64 | 48 | 3 | GO:0071709 | |
| GeneOntologyBiologicalProcess | male mating behavior | 5.46e-04 | 15 | 48 | 2 | GO:0060179 | |
| GeneOntologyBiologicalProcess | negative regulation of excitatory postsynaptic potential | 5.46e-04 | 15 | 48 | 2 | GO:0090394 | |
| GeneOntologyBiologicalProcess | stress-activated protein kinase signaling cascade | 5.56e-04 | 69 | 48 | 3 | GO:0031098 | |
| GeneOntologyBiologicalProcess | membrane biogenesis | 6.56e-04 | 73 | 48 | 3 | GO:0044091 | |
| GeneOntologyBiologicalProcess | presynapse organization | 6.56e-04 | 73 | 48 | 3 | GO:0099172 | |
| GeneOntologyBiologicalProcess | social behavior | 6.83e-04 | 74 | 48 | 3 | GO:0035176 | |
| GeneOntologyBiologicalProcess | catechol-containing compound metabolic process | 6.83e-04 | 74 | 48 | 3 | GO:0009712 | |
| GeneOntologyBiologicalProcess | reproductive behavior | 6.83e-04 | 74 | 48 | 3 | GO:0019098 | |
| GeneOntologyBiologicalProcess | catecholamine metabolic process | 6.83e-04 | 74 | 48 | 3 | GO:0006584 | |
| GeneOntologyBiologicalProcess | 3'-phosphoadenosine 5'-phosphosulfate metabolic process | 7.05e-04 | 17 | 48 | 2 | GO:0050427 | |
| GeneOntologyBiologicalProcess | purine ribonucleoside bisphosphate metabolic process | 7.05e-04 | 17 | 48 | 2 | GO:0034035 | |
| GeneOntologyBiologicalProcess | ethanol catabolic process | 7.05e-04 | 17 | 48 | 2 | GO:0006068 | |
| GeneOntologyBiologicalProcess | biological process involved in intraspecies interaction between organisms | 7.38e-04 | 76 | 48 | 3 | GO:0051703 | |
| GeneOntologyBiologicalProcess | ethanol metabolic process | 7.92e-04 | 18 | 48 | 2 | GO:0006067 | |
| GeneOntologyBiologicalProcess | response to corticosteroid | 8.96e-04 | 185 | 48 | 4 | GO:0031960 | |
| GeneOntologyCellularComponent | symmetric, GABA-ergic, inhibitory synapse | 4.54e-08 | 4 | 48 | 3 | GO:0098983 | |
| GeneOntologyCellularComponent | symmetric synapse | 3.20e-06 | 13 | 48 | 3 | GO:0032280 | |
| GeneOntologyCellularComponent | asymmetric, glutamatergic, excitatory synapse | 2.22e-05 | 24 | 48 | 3 | GO:0098985 | |
| GeneOntologyCellularComponent | inhibitory synapse | 4.88e-05 | 31 | 48 | 3 | GO:0060077 | |
| GeneOntologyCellularComponent | glycinergic synapse | 9.55e-04 | 20 | 48 | 2 | GO:0098690 | |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | 1.16e-03 | 201 | 48 | 4 | GO:0099634 | |
| GeneOntologyCellularComponent | nuclear envelope | 1.70e-03 | 560 | 48 | 6 | GO:0005635 | |
| GeneOntologyCellularComponent | excitatory synapse | 1.91e-03 | 107 | 48 | 3 | GO:0060076 | |
| HumanPheno | Abnormal play | 3.60e-05 | 4 | 13 | 2 | HP:5200104 | |
| HumanPheno | Lack of spontaneous play | 3.60e-05 | 4 | 13 | 2 | HP:0000721 | |
| HumanPheno | Insistence on sameness | 8.97e-05 | 6 | 13 | 2 | HP:5200130 | |
| HumanPheno | Inflexible adherence to routines | 8.97e-05 | 6 | 13 | 2 | HP:0000732 | |
| Domain | Nlgn | 1.49e-07 | 5 | 47 | 3 | IPR000460 | |
| Domain | Carboxylesterase_B_CS | 4.20e-06 | 13 | 47 | 3 | IPR019819 | |
| Domain | CARBOXYLESTERASE_B_2 | 5.33e-06 | 14 | 47 | 3 | PS00941 | |
| Domain | COesterase | 5.33e-06 | 14 | 47 | 3 | PF00135 | |
| Domain | CarbesteraseB | 5.33e-06 | 14 | 47 | 3 | IPR002018 | |
| Domain | NLGN4 | 6.20e-06 | 2 | 47 | 2 | IPR030025 | |
| Domain | DUF4195 | 3.71e-05 | 4 | 47 | 2 | PF13836 | |
| Domain | DUF4195 | 3.71e-05 | 4 | 47 | 2 | IPR025243 | |
| Domain | Sp1_fam | 2.75e-04 | 10 | 47 | 2 | IPR030450 | |
| Domain | ZINC_FINGER_C2H2_2 | 6.34e-04 | 775 | 47 | 8 | PS50157 | |
| Domain | ZINC_FINGER_C2H2_1 | 6.45e-04 | 777 | 47 | 8 | PS00028 | |
| Domain | Znf_C2H2-like | 7.55e-04 | 796 | 47 | 8 | IPR015880 | |
| Domain | Znf_C2H2 | 8.13e-04 | 805 | 47 | 8 | IPR007087 | |
| Domain | Poly(ADP-ribose)pol_cat_dom | 8.23e-04 | 17 | 47 | 2 | IPR012317 | |
| Domain | PARP_CATALYTIC | 8.23e-04 | 17 | 47 | 2 | PS51059 | |
| Domain | PARP | 8.23e-04 | 17 | 47 | 2 | PF00644 | |
| Domain | - | 8.23e-04 | 17 | 47 | 2 | 3.90.228.10 | |
| Domain | ZnF_C2H2 | 8.33e-04 | 808 | 47 | 8 | SM00355 | |
| Domain | Znf_C2H2/integrase_DNA-bd | 1.64e-03 | 694 | 47 | 7 | IPR013087 | |
| Domain | WGR_domain | 1.65e-03 | 24 | 47 | 2 | IPR008893 | |
| Domain | - | 3.33e-03 | 119 | 47 | 3 | 3.40.50.1820 | |
| Domain | AB_hydrolase | 3.33e-03 | 119 | 47 | 3 | IPR029058 | |
| Domain | Sulfotransferase_dom | 3.70e-03 | 36 | 47 | 2 | IPR000863 | |
| Domain | Sulfotransfer_1 | 3.70e-03 | 36 | 47 | 2 | PF00685 | |
| Domain | - | 6.82e-03 | 679 | 47 | 6 | 3.30.160.60 | |
| Domain | zf-C2H2 | 7.51e-03 | 693 | 47 | 6 | PF00096 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_PHIP_TO_DNA_ADDUCTS | 7.04e-05 | 5 | 38 | 2 | M47807 | |
| Pathway | REACTOME_NEUREXINS_AND_NEUROLIGINS | 8.49e-05 | 32 | 38 | 3 | MM15326 | |
| Pathway | WP_ARYLAMINE_METABOLISM | 1.05e-04 | 6 | 38 | 2 | M39437 | |
| Pathway | REACTOME_NEUREXINS_AND_NEUROLIGINS | 4.54e-04 | 56 | 38 | 3 | M27616 | |
| Pathway | KEGG_SULFUR_METABOLISM | 5.42e-04 | 13 | 38 | 2 | M18256 | |
| Pubmed | 2.47e-09 | 3 | 48 | 3 | 18628683 | ||
| Pubmed | 2.47e-09 | 3 | 48 | 3 | 32011705 | ||
| Pubmed | 9.86e-09 | 4 | 48 | 3 | 16077734 | ||
| Pubmed | 9.86e-09 | 4 | 48 | 3 | 17292328 | ||
| Pubmed | Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. | 9.86e-09 | 4 | 48 | 3 | 12669065 | |
| Pubmed | Homodimerization and isoform-specific heterodimerization of neuroligins. | 9.86e-09 | 4 | 48 | 3 | 22671294 | |
| Pubmed | 9.86e-09 | 4 | 48 | 3 | 20579107 | ||
| Pubmed | Synapse formation: if it looks like a duck and quacks like a duck ... | 2.46e-08 | 5 | 48 | 3 | 10996085 | |
| Pubmed | 2.46e-08 | 5 | 48 | 3 | 37865312 | ||
| Pubmed | 4.92e-08 | 6 | 48 | 3 | 21838267 | ||
| Pubmed | 4.92e-08 | 6 | 48 | 3 | 29724786 | ||
| Pubmed | Neuroligin-1 Signaling Controls LTP and NMDA Receptors by Distinct Molecular Pathways. | 1.37e-07 | 8 | 48 | 3 | 30871858 | |
| Pubmed | 2.06e-07 | 9 | 48 | 3 | 23010509 | ||
| Pubmed | 4.04e-07 | 11 | 48 | 3 | 32973045 | ||
| Pubmed | 4.04e-07 | 11 | 48 | 3 | 26403076 | ||
| Pubmed | Advancing the understanding of autism disease mechanisms through genetics. | 6.99e-07 | 13 | 48 | 3 | 27050589 | |
| Pubmed | 1.11e-06 | 15 | 48 | 3 | 18227507 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 20417180 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 16508939 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 29106499 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 27782075 | ||
| Pubmed | NLGN3/NLGN4 gene mutations are not responsible for autism in the Quebec population. | 1.87e-06 | 2 | 48 | 2 | 15389766 | |
| Pubmed | Not all neuroligin 3 and 4X missense variants lead to significant functional inactivation. | 1.87e-06 | 2 | 48 | 2 | 28948087 | |
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 26456829 | ||
| Pubmed | Nlgn4 knockout induces network hypo-excitability in juvenile mouse somatosensory cortex in vitro. | 1.87e-06 | 2 | 48 | 2 | 24104404 | |
| Pubmed | Association between functional genetic polymorphisms of human sulfotransferases 1A1 and 1A2. | 1.87e-06 | 2 | 48 | 2 | 10762004 | |
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 9566757 | ||
| Pubmed | Single nucleotide polymorphisms in SULT1A1 and SULT1A2 in a Korean population. | 1.87e-06 | 2 | 48 | 2 | 23358261 | |
| Pubmed | A Cluster of Autism-Associated Variants on X-Linked NLGN4X Functionally Resemble NLGN4Y. | 1.87e-06 | 2 | 48 | 2 | 32243781 | |
| Pubmed | Novel splice isoforms for NLGN3 and NLGN4 with possible implications in autism. | 1.87e-06 | 2 | 48 | 2 | 16648374 | |
| Pubmed | A substitution involving the NLGN4 gene associated with autistic behavior in the Greek population. | 1.87e-06 | 2 | 48 | 2 | 19645625 | |
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 22989184 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 18434543 | ||
| Pubmed | Mutation screening of X-chromosomal neuroligin genes: no mutations in 196 autism probands. | 1.87e-06 | 2 | 48 | 2 | 15274046 | |
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 11207031 | ||
| Pubmed | Genetic polymorphisms of sulfotransferases (SULT1A1 and SULT1A2) in a Turkish population. | 1.87e-06 | 2 | 48 | 2 | 20936502 | |
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 12469224 | ||
| Pubmed | Variations analysis of NLGN3 and NLGN4X gene in Chinese autism patients. | 1.87e-06 | 2 | 48 | 2 | 24570023 | |
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 18189281 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 16133548 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 23183221 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 8033246 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 24855039 | ||
| Pubmed | Analysis of the genes encoding neuroligins NLGN3 and NLGN4 in Bulgarian patients with autism. | 1.87e-06 | 2 | 48 | 2 | 23431752 | |
| Pubmed | Sex-specific microglia state in the Neuroligin-4 knock-out mouse model of autism spectrum disorder. | 1.87e-06 | 2 | 48 | 2 | 37001827 | |
| Pubmed | Disorder-associated mutations lead to functional inactivation of neuroligins. | 1.87e-06 | 2 | 48 | 2 | 15150161 | |
| Pubmed | Primary structures and properties of two related forms of aryl sulfotransferases in human liver. | 1.87e-06 | 2 | 48 | 2 | 7581483 | |
| Pubmed | Analysis of the neuroligin 3 and 4 genes in autism and other neuropsychiatric patients. | 1.87e-06 | 2 | 48 | 2 | 15622415 | |
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 23851596 | ||
| Pubmed | Increased Network Inhibition in the Dentate Gyrus of Adult Neuroligin-4 Knock-Out Mice. | 1.87e-06 | 2 | 48 | 2 | 37080762 | |
| Pubmed | The HSF1-PARP13-PARP1 complex facilitates DNA repair and promotes mammary tumorigenesis. | 5.59e-06 | 3 | 48 | 2 | 29158484 | |
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 8912648 | ||
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 19369898 | ||
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 26455829 | ||
| Pubmed | Significance of neurexin and neuroligin polymorphisms in regulating risk of Hirschsprung's disease. | 5.59e-06 | 3 | 48 | 2 | 29622757 | |
| Pubmed | Neuroligin-4 is localized to glycinergic postsynapses and regulates inhibition in the retina. | 5.59e-06 | 3 | 48 | 2 | 21282647 | |
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 18259693 | ||
| Pubmed | DSCAM Deficiency Leads to Premature Spine Maturation and Autism-like Behaviors. | 6.27e-06 | 26 | 48 | 3 | 34848499 | |
| Pubmed | SPATA2-Mediated Binding of CYLD to HOIP Enables CYLD Recruitment to Signaling Complexes. | 8.98e-06 | 353 | 48 | 6 | 27545878 | |
| Pubmed | 1.12e-05 | 4 | 48 | 2 | 8661000 | ||
| Pubmed | 1.12e-05 | 4 | 48 | 2 | 8943792 | ||
| Pubmed | 1.12e-05 | 4 | 48 | 2 | 8288252 | ||
| Pubmed | A single mutation converts the nucleotide specificity of phenol sulfotransferase from PAP to AMP. | 1.12e-05 | 4 | 48 | 2 | 12390022 | |
| Pubmed | 1.12e-05 | 4 | 48 | 2 | 24318996 | ||
| Pubmed | 1.12e-05 | 4 | 48 | 2 | 8424956 | ||
| Pubmed | 1.12e-05 | 4 | 48 | 2 | 25370010 | ||
| Pubmed | 1.12e-05 | 4 | 48 | 2 | 33414449 | ||
| Pubmed | 1.12e-05 | 4 | 48 | 2 | 23468870 | ||
| Pubmed | Neurexins induce differentiation of GABA and glutamate postsynaptic specializations via neuroligins. | 1.86e-05 | 5 | 48 | 2 | 15620359 | |
| Pubmed | 1.86e-05 | 5 | 48 | 2 | 26169578 | ||
| Pubmed | 1.86e-05 | 5 | 48 | 2 | 11389699 | ||
| Pubmed | 1.86e-05 | 5 | 48 | 2 | 29908303 | ||
| Pubmed | Neuroligins and neurexins link synaptic function to cognitive disease. | 1.86e-05 | 5 | 48 | 2 | 18923512 | |
| Pubmed | 1.86e-05 | 5 | 48 | 2 | 24802129 | ||
| Pubmed | 1.86e-05 | 5 | 48 | 2 | 25053625 | ||
| Pubmed | Genome-wide reprogramming in the mouse germ line entails the base excision repair pathway. | 3.90e-05 | 7 | 48 | 2 | 20595612 | |
| Pubmed | 3.90e-05 | 7 | 48 | 2 | 9370299 | ||
| Pubmed | 3.90e-05 | 7 | 48 | 2 | 12438748 | ||
| Pubmed | Alternative splicing, gene localization, and binding of SH2-B to the insulin receptor kinase domain. | 5.19e-05 | 8 | 48 | 2 | 10594240 | |
| Pubmed | RC3H1 post-transcriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-κB pathway. | 6.50e-05 | 156 | 48 | 4 | 26170170 | |
| Pubmed | Genetic Screens Reveal FEN1 and APEX2 as BRCA2 Synthetic Lethal Targets. | 6.66e-05 | 157 | 48 | 4 | 30686591 | |
| Pubmed | 6.67e-05 | 9 | 48 | 2 | 9166597 | ||
| Pubmed | 6.67e-05 | 9 | 48 | 2 | 17509151 | ||
| Pubmed | Chromosomal localization of the mouse genes encoding the ERK1 and ERK2 isoforms of MAP kinases. | 6.67e-05 | 9 | 48 | 2 | 9060415 | |
| Pubmed | 6.67e-05 | 9 | 48 | 2 | 8887328 | ||
| Pubmed | Microglia ablation alleviates myelin-associated catatonic signs in mice. | 6.67e-05 | 9 | 48 | 2 | 29252214 | |
| Pubmed | 6.67e-05 | 9 | 48 | 2 | 9177785 | ||
| Pubmed | Ethanol sulfation by the human cytosolic sulfotransferases: a systematic analysis. | 6.67e-05 | 9 | 48 | 2 | 23207770 | |
| Pubmed | 6.67e-05 | 9 | 48 | 2 | 8468045 | ||
| Pubmed | 6.67e-05 | 9 | 48 | 2 | 19548878 | ||
| Pubmed | 6.67e-05 | 9 | 48 | 2 | 9278515 | ||
| Pubmed | 7.60e-05 | 59 | 48 | 3 | 32382008 | ||
| Pubmed | 8.33e-05 | 10 | 48 | 2 | 7601475 | ||
| Pubmed | Human cytosolic sulphotransferases: genetics, characteristics, toxicological aspects. | 8.33e-05 | 10 | 48 | 2 | 11535246 | |
| Pubmed | Localization of the murine cholecystokinin A and B receptor genes. | 1.02e-04 | 11 | 48 | 2 | 7613026 | |
| Pubmed | 1.02e-04 | 11 | 48 | 2 | 11154739 | ||
| Pubmed | Sulfation and sulfotransferases 1: Sulfotransferase molecular biology: cDNAs and genes. | 1.02e-04 | 11 | 48 | 2 | 9034160 | |
| Pubmed | 1.02e-04 | 11 | 48 | 2 | 10720750 | ||
| Pubmed | Tbx6, a mouse T-Box gene implicated in paraxial mesoderm formation at gastrulation. | 1.02e-04 | 11 | 48 | 2 | 8954725 | |
| Pubmed | 1.08e-04 | 1084 | 48 | 8 | 11544199 | ||
| Cytoband | 10q24.1 | 2.44e-04 | 22 | 48 | 2 | 10q24.1 | |
| Cytoband | 22q11.22 | 2.67e-04 | 23 | 48 | 2 | 22q11.22 | |
| Cytoband | 16p12.1 | 3.16e-04 | 25 | 48 | 2 | 16p12.1 | |
| Cytoband | 8p22 | 8.14e-04 | 40 | 48 | 2 | 8p22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr8p22 | 1.12e-03 | 47 | 48 | 2 | chr8p22 | |
| Cytoband | Xq13.1 | 1.17e-03 | 48 | 48 | 2 | Xq13.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr8p21 | 8.86e-03 | 135 | 48 | 2 | chr8p21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q33 | 9.24e-03 | 138 | 48 | 2 | chr9q33 | |
| GeneFamily | Zinc fingers C2H2-type|Sp transcription factors | 1.23e-04 | 9 | 34 | 2 | 755 | |
| GeneFamily | Sulfotransferases, cytosolic | 3.08e-04 | 14 | 34 | 2 | 762 | |
| GeneFamily | Zinc fingers|Zinc fingers PARP-type|Poly(ADP-ribose) polymerases | 4.59e-04 | 17 | 34 | 2 | 684 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 1.04e-02 | 718 | 34 | 5 | 28 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder urothelium (LCM)_emap-30380_top-relative-expression-ranked_500 | 1.43e-04 | 389 | 44 | 6 | gudmap_developingLowerUrinaryTract_P2_bladder urothelium (LCM)_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder urothelium (LCM)_emap-30380_k-means-cluster#5_top-relative-expression-ranked_500 | 1.55e-04 | 131 | 44 | 4 | gudmap_developingLowerUrinaryTract_P2_bladder urothelium (LCM)_500_k5 | |
| CoexpressionAtlas | seminal vesicle | 1.69e-04 | 134 | 44 | 4 | seminal vesicle | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder urothelium (LCM)_emap-30380_top-relative-expression-ranked_1000 | 1.72e-04 | 778 | 44 | 8 | gudmap_developingLowerUrinaryTract_P2_bladder urothelium (LCM)_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder urothelium (LCM)_emap-30380_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.02e-04 | 262 | 44 | 5 | gudmap_developingLowerUrinaryTract_P2_bladder urothelium (LCM)_1000_k2 | |
| CoexpressionAtlas | gudmap_RNAseq_p2_Glomerlular Endothelial_2500_K2 | 2.32e-04 | 270 | 44 | 5 | gudmap_RNAseq_p2_Glomerlular Endothelial_2500_K2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_500 | 2.36e-04 | 427 | 44 | 6 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_1000 | 2.42e-04 | 818 | 44 | 8 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_1000 | 2.51e-04 | 822 | 44 | 8 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_1000 | |
| ToppCell | NS-critical-d_16-33-Myeloid-Mast_cell|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.08e-07 | 160 | 48 | 5 | c61869d9dbba250270e59366e15af204e5b4395d | |
| ToppCell | droplet-Kidney-nan-3m-Endothelial-nan|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-06 | 186 | 48 | 5 | d72cdbb6d79ab33a5823c42e93c2ba566244f64c | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Endothelial-fenestrated_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-06 | 192 | 48 | 5 | 5dd206adb8b84c374ee931f7df2a8b8cf040efab | |
| ToppCell | droplet-Kidney-nan-3m-Endothelial-fenestrated_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-06 | 192 | 48 | 5 | 85be54c2cba8eab4c6ef2a85a526f7a9db4cfe73 | |
| ToppCell | droplet-Kidney-nan-3m-Endothelial-Pecam____fenestrated_capillary_endothelial|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-06 | 192 | 48 | 5 | 31a9142d97b690992aabee1a181650deb1a44253 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Endothelial-Pecam____fenestrated_capillary_endothelial|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-06 | 192 | 48 | 5 | 1a2dd398141069ef6ad2f6bb4bae0bac1c6b98e8 | |
| ToppCell | droplet-Kidney-nan-21m-Endothelial-fenestrated_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.14e-06 | 195 | 48 | 5 | 37d22a6448db1f83d098018fbb75a6dd8d9be302 | |
| ToppCell | droplet-Kidney-nan-21m-Endothelial-Pecam____fenestrated_capillary_endothelial|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.14e-06 | 195 | 48 | 5 | 37592b7ad912b381b1edc77f4032983f26e0aa5b | |
| ToppCell | NS-critical-LOC-Myeloid-Basophil|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.65e-05 | 160 | 48 | 4 | 8a4746463ca1976f7d6de803496c851249ced797 | |
| ToppCell | NS-moderate-d_16-33-Myeloid-Mast_cell|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.92e-05 | 164 | 48 | 4 | 35c673380f75cb4bfe080089bc723c4373bcc7a5 | |
| ToppCell | P15-Epithelial-airway_epithelial_cell-ciliated_cell_of_airway|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.14e-05 | 167 | 48 | 4 | 5c3d0763f73628c71c71f9883556bb4f1639f3cc | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Myeloid-microglial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.68e-05 | 174 | 48 | 4 | 8d6df5938cef542f23259ce471eea1a1afbed03c | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Myeloid|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.68e-05 | 174 | 48 | 4 | 2af54c3427aacfa232e2aca6003b4a8ecb8bba66 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Myeloid-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.68e-05 | 174 | 48 | 4 | eca643b8f5b92aeed5a77c94b4301fd8100f9401 | |
| ToppCell | facs-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.20e-05 | 180 | 48 | 4 | 67c5068b660cd5e727a665cefe3bd5f8ae887221 | |
| ToppCell | droplet-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.77e-05 | 186 | 48 | 4 | 9c7924875f70420720149287c500b4dfa8d24673 | |
| ToppCell | droplet-Kidney-nan-3m-Endothelial-kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.87e-05 | 187 | 48 | 4 | d72012e94857606f39975cf672f6b8c2e0fe093e | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Endothelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.98e-05 | 188 | 48 | 4 | 51c6796a9488c056a10d048082015342c2e037f9 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Endothelial-kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.98e-05 | 188 | 48 | 4 | b651024d58ed1bcfe0d80b21755f8bf709eda81f | |
| ToppCell | droplet-Lung-nan-18m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.98e-05 | 188 | 48 | 4 | 405efea75233ecf70f7d19b630230798d817b7f2 | |
| ToppCell | droplet-Kidney-nan-18m-Endothelial-fenestrated_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.08e-05 | 189 | 48 | 4 | 91261fe86f0d54b9697f85bb4d3ebdc8975b1bfa | |
| ToppCell | droplet-Kidney-nan-18m-Endothelial-Pecam____fenestrated_capillary_endothelial|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.08e-05 | 189 | 48 | 4 | 88c0dda28f072368c0df30fc82ee3af9c7670f6c | |
| ToppCell | droplet-Kidney-nan-3m-Endothelial|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.29e-05 | 191 | 48 | 4 | dc58d45fafd224d2761aefbe0ce79f66b50c1c03 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Endothelial|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.29e-05 | 191 | 48 | 4 | 767269dbd799e08c4ebba13e8c968fb148acf182 | |
| ToppCell | control-Myeloid-Mast_cell|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.29e-05 | 191 | 48 | 4 | afebdc59a1f884ce3f2f5fe040e16b0e95e4e7c5 | |
| ToppCell | facs-Thymus-Epithelium-24m-Endothelial|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.40e-05 | 192 | 48 | 4 | 39afea574725ce0c67afdd79facdb34f819a828d | |
| ToppCell | droplet-Mammary_Gland-nan-18m-Endothelial-endothelial_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.40e-05 | 192 | 48 | 4 | 945153c41dde6e90d103206955e1707b54eb0665 | |
| ToppCell | facs-Thymus-Epithelium-24m-Endothelial-endothelial_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.40e-05 | 192 | 48 | 4 | 597db951b1fbc37db22134c3d27d3ec4ceaa85f7 | |
| ToppCell | facs-Thymus-Epithelium-24m-Endothelial-endothelial_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.40e-05 | 192 | 48 | 4 | bc275a9eccb1c7a46fd58b15ca5acdd9f7495842 | |
| ToppCell | droplet-Mammary_Gland-nan-18m-Endothelial|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.40e-05 | 192 | 48 | 4 | 6ab50579c63f31ca2cd41063a99b129f11c07510 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-E-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.51e-05 | 193 | 48 | 4 | 5c6b03d6d98aa873fda1a201d44a912246bb5a92 | |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_-NAF_endoneurial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.51e-05 | 193 | 48 | 4 | 549a0b750c860b615aff767ad04c9a9d20f802f0 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-E|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.51e-05 | 193 | 48 | 4 | d4b58eee97043b4337ec36c40f9af6499d864df9 | |
| ToppCell | P15-Endothelial-large_vessel_endothelial_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.51e-05 | 193 | 48 | 4 | 5f9a7cd5f8eb9ac294cdb50518fedf872f3f78f5 | |
| ToppCell | droplet-Mammary_Gland-nan-18m-Endothelial-endothelial_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.73e-05 | 195 | 48 | 4 | 4db30b3bc65c25626f828cd4f867f20c71809898 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-E_(AT2)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.08e-05 | 198 | 48 | 4 | 85215015bb86ada0e871c413a4ecdc903a3785ca | |
| ToppCell | 367C-Epithelial_cells-Epithelial-E_(AT2)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.08e-05 | 198 | 48 | 4 | 38349e42a3f1fb700ff6dfd89c4bf5ff97f1a3e9 | |
| ToppCell | Biopsy_IPF-Epithelial-AT2|Biopsy_IPF / Sample group, Lineage and Cell type | 6.20e-05 | 199 | 48 | 4 | c841d475703d3489161fb7904526bd7563d5fb0f | |
| ToppCell | LPS-IL1RA-Unknown-Endothelial-Pericyte_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.30e-04 | 125 | 48 | 3 | 2938a1d62afe1e0a3abba5eb92f07b886cc0accd | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Ductal_and_Papillary_Carcinoma|TCGA-Breast / Sample_Type by Project: Shred V9 | 4.32e-04 | 137 | 48 | 3 | 2a5d2a99a2c532480d00b80a4885514a8a5c80fa | |
| ToppCell | Control-Epithelial_alveolar-AT_1-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.41e-04 | 138 | 48 | 3 | 611fe0fb284e12678f9c47a0bdbfc367a93c52b3 | |
| ToppCell | COVID-19_Severe-MAIT|World / disease group, cell group and cell class | 5.10e-04 | 145 | 48 | 3 | 8d63f97812f63329ef9c940b291dc5a1c4d90690 | |
| ToppCell | Severe-Myeloid-Mast-|Severe / Condition, Lineage, Cell class and cell subclass | 5.10e-04 | 145 | 48 | 3 | ce307d45425a5191882078f049f85477eec40b69 | |
| ToppCell | Severe-Myeloid-Mast|Severe / Condition, Lineage, Cell class and cell subclass | 5.10e-04 | 145 | 48 | 3 | e0bfd2ffdbd6c197ef0a04e983396ebd87ef7127 | |
| ToppCell | IIH-CD8-proli_CD4|IIH / Condition, Cell_class and T cell subcluster | 5.20e-04 | 146 | 48 | 3 | 7fa6e35def3f7cffbee1e1c2f10b523bab678e14 | |
| ToppCell | COVID-19_Severe-MAIT|COVID-19_Severe / disease group, cell group and cell class | 5.63e-04 | 150 | 48 | 3 | 923ea7ecc0aa05fb0396082cd9c3d1594135f1e0 | |
| ToppCell | E17.5-Epithelial-airway_epithelial_cell-ciliated_cell_of_airway|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.63e-04 | 150 | 48 | 3 | 201d5b68e71c6c003285428be96c488e6d526edf | |
| ToppCell | Int-URO-Other|Int-URO / Disease, Lineage and Cell Type | 5.74e-04 | 151 | 48 | 3 | ea5f25842e621be41a6491c9959d419d9cc7ebd6 | |
| ToppCell | Int-URO-Other-RBC|Int-URO / Disease, Lineage and Cell Type | 5.74e-04 | 151 | 48 | 3 | 0344d482f1c55c9eaa15beb8d6bac1c6cdca21b3 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-myeloid-myeloid_granulocytic|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.85e-04 | 152 | 48 | 3 | 32634195048858ae84605c61e43c542d90f7cab5 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-myeloid-myeloid_granulocytic-mast_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.85e-04 | 152 | 48 | 3 | 0eb185b2404f015efff1bd140e0c502d714720fb | |
| ToppCell | NS-moderate-d_07-13-Myeloid-Mast_cell|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.31e-04 | 156 | 48 | 3 | 17c38d3b03fc38cb125cf0d165b2fd694cd88edd | |
| ToppCell | Adult-Immune-mast_cell-D231|Adult / Lineage, Cell type, age group and donor | 6.43e-04 | 157 | 48 | 3 | 4c63bb91f8708644e6ce2500072a4eeb8e1079dd | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-Like-AT1_Progenitor|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.43e-04 | 157 | 48 | 3 | a93866f051472506f1468f379c0d5313e02c9731 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-myeloid-myeloid_granulocytic-mast_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.67e-04 | 159 | 48 | 3 | ecd1daa33549541aee3bf4e139ab6732efc8e74c | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-myeloid-myeloid_granulocytic|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.67e-04 | 159 | 48 | 3 | 7b6370c9567da7d40541c6e243efa704ed7e90ae | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Neural-neural_cell-Schwann_Cell_/_Neural|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.79e-04 | 160 | 48 | 3 | 14dfa519e68bab4bce890ddb66fa7763f18d9f19 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Neural|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.79e-04 | 160 | 48 | 3 | 5b7789d4668ed7732babedc32d812233b430e0bd | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Neural-neural_cell-Schwann_Cell_/_Neural-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.79e-04 | 160 | 48 | 3 | bba1486faaad5299e10f4fe17c6d149c28dc2560 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Neural-neural_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.79e-04 | 160 | 48 | 3 | 839bbdfd4e4c7b48260c8bfb7670378634405e1d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.91e-04 | 161 | 48 | 3 | 1b805f77790aeb8a71b08bfac2fe2eed7343258f | |
| ToppCell | BL-critical-LOC-Myeloid-Basophil|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.04e-04 | 162 | 48 | 3 | 25ec9df914445b4daae4fd28fd0e60b64797c46d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Neural-neural_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.04e-04 | 162 | 48 | 3 | d28b2ea1d2c8f3c6a107991573471b6d0c49c4ae | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Neural-neural_cell-Schwann_Cell_/_Neural|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.04e-04 | 162 | 48 | 3 | eed223e61c8162a2fe004ab4e09de5e037be7553 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Neural-neural_cell-Schwann_Cell_/_Neural-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.04e-04 | 162 | 48 | 3 | 5bbd7130d4dad9035e73a439dda568195c136f31 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Neural|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.04e-04 | 162 | 48 | 3 | e35ddce830e20ebeac1a2c405293fc4a5323dd4a | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Myeloid-Monocytic-Nonclassical_Monocyte|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.29e-04 | 164 | 48 | 3 | 17d5b8bb7c015cf9f0d6e578a0d212eada39cb93 | |
| ToppCell | Mild-Myeloid-Mast-|Mild / Condition, Lineage, Cell class and cell subclass | 7.42e-04 | 165 | 48 | 3 | 93d3909a0f5f43d473d5005c842d7d73e25eceed | |
| ToppCell | critical-Myeloid-Mast_cell|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.42e-04 | 165 | 48 | 3 | 34a1cc6ccd46c059354e8fbde1ac69f202695a4e | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Epithelial-Tuft-related-Tuft|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.42e-04 | 165 | 48 | 3 | 34fd00be2b28716c871ad9fb356de84a299a0c01 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.42e-04 | 165 | 48 | 3 | 9acf03b5a20170721380045b5c268825e8f315dd | |
| ToppCell | Mild-Myeloid-Mast|Mild / Condition, Lineage, Cell class and cell subclass | 7.42e-04 | 165 | 48 | 3 | 5fa9552c37890c5cc7e672a47038aebba2413cb4 | |
| ToppCell | moderate-Myeloid-Mast_cell|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.55e-04 | 166 | 48 | 3 | c3835b424c63bf11a4e2c47635dc3787fc4a637a | |
| ToppCell | 368C-Myeloid-Monocyte-CD16+_Monocyte|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 7.68e-04 | 167 | 48 | 3 | dbd2b9f2f4ba7be5fdf8318094e6b078cb1d1c43 | |
| ToppCell | NS-critical-d_07-13-Myeloid-Mast_cell|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.68e-04 | 167 | 48 | 3 | 8a14fd980d8ebe8ef0216221f619d31aaa27ff15 | |
| ToppCell | facs-Skin-Anagen-24m-Epithelial-epidermal_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.68e-04 | 167 | 48 | 3 | 02c89069dcd0e87f7502e32b14e7cbd3cab81a09 | |
| ToppCell | 10x5'-lymph-node_spleen-Mast-Mast_cells|lymph-node_spleen / Manually curated celltypes from each tissue | 7.82e-04 | 168 | 48 | 3 | 650ad3ea52577887885d82457dbc04202ce3eb34 | |
| ToppCell | ASK428-Immune-Mast_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq | 7.82e-04 | 168 | 48 | 3 | c399fcb4d1d0be48026c2ecabc34a5935e7adf73 | |
| ToppCell | 10x5'-lymph-node_spleen-Mast|lymph-node_spleen / Manually curated celltypes from each tissue | 7.82e-04 | 168 | 48 | 3 | e58ffbb57c81967766755c3f6f347b158a39cb0d | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Myeloid_Dendritic_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.95e-04 | 169 | 48 | 3 | 46f0f0de9a0894c454f93032e7a7a800f47c8276 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Hematologic-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.95e-04 | 169 | 48 | 3 | 4e1322cc5e1733e9fb19e08f739a30206f43cea8 | |
| ToppCell | droplet-Spleen-nan-3m-Myeloid-granulocyte|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.09e-04 | 170 | 48 | 3 | dbd6c9c7be824a1ff1b31af791064127cafbd194 | |
| ToppCell | 368C-Myeloid-Monocyte-CD16+_Monocyte|Monocyte / Donor, Lineage, Cell class and subclass (all cells) | 8.09e-04 | 170 | 48 | 3 | 4a19c7e3bb0f9c2601a10debe7000066789b4150 | |
| ToppCell | droplet-Marrow-BM-1m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.23e-04 | 171 | 48 | 3 | 8a0c08f0aa3a80cd6346c81deb242e430ebd897b | |
| ToppCell | 3'_v3-GI_small-bowel-Mast-Mast_cell_granulo-myelo|GI_small-bowel / Manually curated celltypes from each tissue | 8.37e-04 | 172 | 48 | 3 | 3df11aefc09762fd1f94441324551178e030b249 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.37e-04 | 172 | 48 | 3 | 553701349444eb366df3c11f54bb093434f153c6 | |
| ToppCell | control-Myeloid-Mast_cell|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 8.37e-04 | 172 | 48 | 3 | c1c99e6732234a6649a79610e99390db0c8f19b0 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.37e-04 | 172 | 48 | 3 | 08a3fe536b1b064c5ee7779bc2b1115a5963a26b | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Hematopoietic-Myeloid-CLC+_Mast_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.37e-04 | 172 | 48 | 3 | 2ab720a4c96073339a1f8b95ec7699682df98acf | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.51e-04 | 173 | 48 | 3 | 4968712af1cca8c932abd3323631d7dcaffd4a66 | |
| ToppCell | (6)_Endothelial_cells-(6)_Endothelial-E|(6)_Endothelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 8.65e-04 | 174 | 48 | 3 | 4a1b67ce5ea353b3f81f59fa57da07668146afca | |
| ToppCell | 10x5'-GI_small-bowel-Mast|GI_small-bowel / Manually curated celltypes from each tissue | 8.65e-04 | 174 | 48 | 3 | e94c980b25edfd0e8598c416828801fcc00e8ead | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.65e-04 | 174 | 48 | 3 | 9c916af5eebd932f67dc9117e1d26ff194a2ff2c | |
| ToppCell | 10x5'-GI_small-bowel-Mast-Mast_cells|GI_small-bowel / Manually curated celltypes from each tissue | 8.65e-04 | 174 | 48 | 3 | 05525bf0a2bde2be4f7c147b17a24530ce8819e0 | |
| ToppCell | NS-control-d_0-4-Myeloid-Mast_cell|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.65e-04 | 174 | 48 | 3 | 2d1f5c17b1551f32f49618ec1bf68eafbfd02ace | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.65e-04 | 174 | 48 | 3 | bc71521f44a5fe013af42b06b5d1bd2446ecf3b5 | |
| ToppCell | facs-Limb_Muscle-Muscle_Diaphragm-18m-Lymphocytic-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.80e-04 | 175 | 48 | 3 | db6be3e9e339918418fcaf9001ea15207aa6c993 | |
| ToppCell | moderate-Myeloid-Mast_cell|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 8.80e-04 | 175 | 48 | 3 | bbd2971bc6d69e507f90a637834d0936c205c590 | |
| ToppCell | droplet-Spleen-nan-3m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.80e-04 | 175 | 48 | 3 | 21bc0e59a9509d38751ce6aad2325f341bc70eff | |
| ToppCell | facs-Kidney-nan-18m-Epithelial-epithelial_cell_of_proximal_tubule|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.80e-04 | 175 | 48 | 3 | 076ad81d6cbeea5512393d192af3ab5aa1f82975 | |
| Drug | 2-amino-3-methyl-9H-pyrido(2,3-b)indole | 1.34e-06 | 11 | 47 | 3 | ctd:C017821 | |
| Drug | 5-hydroxymethylfurfural | 4.17e-06 | 2 | 47 | 2 | ctd:C008046 | |
| Drug | sodium phosphate monohydrate | 9.17e-06 | 20 | 47 | 3 | CID000061456 | |
| Drug | 5-hydroxy-3-methylindole | 1.25e-05 | 3 | 47 | 2 | CID000192734 | |
| Drug | AalphaC | 1.62e-05 | 24 | 47 | 3 | CID000062805 | |
| Drug | alpha-methyldopamine | 2.07e-05 | 26 | 47 | 3 | CID000017005 | |
| Drug | Chebi:32701 | 2.50e-05 | 4 | 47 | 2 | CID005460855 | |
| Drug | fipronil | 2.72e-05 | 597 | 47 | 8 | ctd:C082360 | |
| Drug | Glu-P-2 | 2.90e-05 | 29 | 47 | 3 | CID000049970 | |
| Drug | TKPP | 4.15e-05 | 5 | 47 | 2 | CID000023740 | |
| Drug | F0447-0125; Down 200; 10uM; MCF7; HT_HG-U133A | 5.01e-05 | 195 | 47 | 5 | 6424_DN | |
| Drug | mefenamic acid | 6.10e-05 | 37 | 47 | 3 | CID000004044 | |
| Drug | galangin | 6.10e-05 | 37 | 47 | 3 | CID005281616 | |
| Drug | 2-Sulfotrehalose | 6.22e-05 | 6 | 47 | 2 | CID000124677 | |
| Drug | Glu-P-2 | 6.22e-05 | 6 | 47 | 2 | ctd:C023847 | |
| Drug | N-hydroxy-2-acetylaminophenanthrene | 6.22e-05 | 6 | 47 | 2 | CID000017102 | |
| Drug | atractylon | 6.22e-05 | 6 | 47 | 2 | CID003080635 | |
| Drug | Pentagastrin | 8.70e-05 | 7 | 47 | 2 | ctd:D010418 | |
| Drug | AC1L577W | 8.70e-05 | 7 | 47 | 2 | CID000171279 | |
| Drug | 2-amino-6-methyldipyrido(1,2-a-3',2'-d)imidazole | 8.70e-05 | 7 | 47 | 2 | ctd:C023785 | |
| Drug | dopamine-4-O-sulfate | 8.70e-05 | 7 | 47 | 2 | CID000123932 | |
| Drug | 2-naphthylsulfate | 8.70e-05 | 7 | 47 | 2 | CID000074428 | |
| Drug | 2-iodo-4-azidophenol | 8.70e-05 | 7 | 47 | 2 | CID003035977 | |
| Drug | N-acetyl-2-naphthylhydroxylamine | 8.70e-05 | 7 | 47 | 2 | CID000017272 | |
| Drug | luciferyl sulfate | 8.70e-05 | 7 | 47 | 2 | CID011953812 | |
| Drug | Phosphoadenosine Phosphosulfate | 8.70e-05 | 7 | 47 | 2 | ctd:D010724 | |
| Drug | L-alpha-methyldopa | 8.94e-05 | 42 | 47 | 3 | CID000004138 | |
| Drug | gallic acid | 9.63e-05 | 116 | 47 | 4 | CID000000370 | |
| Drug | NSC674039 | 1.03e-04 | 44 | 47 | 3 | CID000001249 | |
| Drug | 2-iodophenol | 1.16e-04 | 8 | 47 | 2 | CID000010784 | |
| Drug | dopamine 3-O-sulfate | 1.16e-04 | 8 | 47 | 2 | CID000122136 | |
| Drug | N-hydroxy-4-aminobiphenyl | 1.16e-04 | 8 | 47 | 2 | ctd:C014593 | |
| Drug | 6-anilino-2-thiouracil | 1.16e-04 | 8 | 47 | 2 | CID003037707 | |
| Drug | salicylamide | 1.34e-04 | 48 | 47 | 3 | CID000005147 | |
| Drug | 3-hydroxy-3-methyloxindole | 1.49e-04 | 9 | 47 | 2 | CID000151066 | |
| Drug | AC1L1A6N | 1.49e-04 | 9 | 47 | 2 | CID000000858 | |
| Drug | 8-oxo-dGTP | 1.51e-04 | 50 | 47 | 3 | CID000107902 | |
| Drug | 4-methylumbelliferone | 1.59e-04 | 132 | 47 | 4 | CID003364573 | |
| Drug | sodium rosmarinate | 1.80e-04 | 53 | 47 | 3 | CID000005099 | |
| Drug | 2-amino-9H-pyrido(2,3-b)indole | 1.86e-04 | 10 | 47 | 2 | ctd:C017822 | |
| Drug | xanthohumol | 1.90e-04 | 54 | 47 | 3 | ctd:C104536 | |
| Drug | minoxidil | 1.90e-04 | 54 | 47 | 3 | CID000004201 | |
| Drug | phenacetin | 2.01e-04 | 55 | 47 | 3 | CID000004754 | |
| Drug | MeIQx | 2.01e-04 | 55 | 47 | 3 | CID000062275 | |
| Drug | 2-acetylaminofluorene | 2.01e-04 | 262 | 47 | 5 | CID000005897 | |
| Drug | Piroxicam | 2.21e-04 | 603 | 47 | 7 | ctd:D010894 | |
| Drug | sultopride | 2.27e-04 | 11 | 47 | 2 | CID000005357 | |
| Drug | AC1O4QIW | 2.47e-04 | 59 | 47 | 3 | CID006398478 | |
| Drug | 2-amino-1-methyl-6-phenolimidazo(4,5-b)pyridine-DNA adduct | 2.72e-04 | 12 | 47 | 2 | ctd:C502239 | |
| Drug | 2-aminoacetophenone | 2.72e-04 | 12 | 47 | 2 | CID000011952 | |
| Drug | ZM 230487 | 2.72e-04 | 12 | 47 | 2 | CID000132998 | |
| Drug | 2-nitrosopropane | 2.72e-04 | 12 | 47 | 2 | CID000079121 | |
| Drug | N-(N-acetyl-L-prolyl)-N-nitrosoglycine | 2.72e-04 | 12 | 47 | 2 | CID000107959 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 3.51e-06 | 152 | 45 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | X-12707 measurement | 1.49e-04 | 12 | 45 | 2 | EFO_0800720 | |
| Disease | renal cell carcinoma (biomarker_via_orthology) | 2.05e-04 | 14 | 45 | 2 | DOID:4450 (biomarker_via_orthology) | |
| Disease | ascorbic acid 3-sulfate measurement | 2.05e-04 | 14 | 45 | 2 | EFO_0800173 | |
| Disease | Autosome Abnormalities | 2.69e-04 | 16 | 45 | 2 | C0004403 | |
| Disease | Chromosome Aberrations | 2.69e-04 | 16 | 45 | 2 | C0008625 | |
| Disease | prostate carcinoma | 3.73e-04 | 891 | 45 | 7 | EFO_0001663 | |
| Disease | platelet crit | 5.54e-04 | 952 | 45 | 7 | EFO_0007985 | |
| Disease | Colorectal Carcinoma | 6.56e-04 | 702 | 45 | 6 | C0009402 | |
| Disease | Mammary Neoplasms, Human | 1.19e-03 | 525 | 45 | 5 | C1257931 | |
| Disease | Mammary Carcinoma, Human | 1.19e-03 | 525 | 45 | 5 | C4704874 | |
| Disease | Mammary Neoplasms | 1.21e-03 | 527 | 45 | 5 | C1458155 | |
| Disease | Breast Carcinoma | 1.32e-03 | 538 | 45 | 5 | C0678222 | |
| Disease | autistic disorder (is_implicated_in) | 1.88e-03 | 42 | 45 | 2 | DOID:12849 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HYPGPGNHFWKCLFM | 151 | Q13569 | |
| LFKTAIPYMNHCWRH | 431 | P59817 | |
| FKTATPYMCHYRGHW | 441 | Q86YH2 | |
| LLSSFNFPYLHCMWH | 201 | Q5QJU3 | |
| CAFWVYRHHKMAYPP | 156 | P27037 | |
| WETMHHCKRYRSPEP | 146 | P49761 | |
| VHASCALLYPMRWEH | 231 | Q8IV53 | |
| WCYLVPQHGMCSHKF | 1196 | Q8TE57 | |
| SCPMWAPHSYLYPLH | 711 | Q01804 | |
| SPMFDGKVPHWYHFS | 41 | P09874 | |
| HWQSPHMHAYYPALT | 71 | P19113 | |
| HMHAYYPALTSWPSL | 76 | P19113 | |
| VFIHPESPSTGHYWM | 156 | Q8IWI9 | |
| LHLPTTPCNFMYKFW | 486 | Q9Y216 | |
| SLYTDCPFPKWMHWA | 236 | Q9GZR5 | |
| PRHCKHCPWAHMEKY | 1031 | Q5VYM1 | |
| HCPWAHMEKYLSFPT | 1036 | Q5VYM1 | |
| EHAHIWFSIPICLMY | 21 | Q8NH64 | |
| WPCMVSADPLLHSYT | 236 | O96028 | |
| NHLYHWHPLMPDSFK | 381 | P23219 | |
| FYHHCQSLMKPAWSD | 506 | Q9NZ94 | |
| AFYHHCQSEMKPSWA | 471 | Q8NFZ3 | |
| YNPGHLLPHKWENCM | 281 | Q9BTY2 | |
| PVSDWLFSMWHYSHP | 446 | O75844 | |
| AFYHHCQSEMKPSWA | 471 | Q8N0W4 | |
| HTLVMFYAPWCPHCK | 416 | Q14554 | |
| KVLSYWCFSPGHSMH | 451 | Q9NZ71 | |
| AYGFPWPEMLHCHKF | 141 | Q5T4F7 | |
| PGFTFHAWLCLHPMD | 601 | Q6ZNJ1 | |
| HHVKTMWYPEIKHFC | 116 | Q9BYZ6 | |
| LQPDMSHHYESWFRP | 96 | Q3SY56 | |
| GPHHSMKTEYLAFWL | 196 | Q9C0C4 | |
| HMPEWYTKSFGHLCA | 1491 | Q96QB1 | |
| MAHPYESWFKPSHPG | 181 | Q8IXZ3 | |
| AMLPHDYVAPGHCWL | 781 | Q7Z7M1 | |
| RFCSASLEMPMWHPY | 241 | Q9Y2B4 | |
| YPHLSCFSMKSWPNI | 3466 | Q86UP3 | |
| RCSPMKGHSHVYWYR | 41 | A0A087X0M5 | |
| HFYHMAKVHPEPGTW | 141 | P50225 | |
| HFYHMAKVYPHPGTW | 141 | P50226 | |
| YFMKLHHCPGNHSWD | 381 | O43353 | |
| LWFTVIYDDPMHHPC | 226 | O00624 | |
| MWHHGELPSYPCEMC | 141 | Q6AHZ1 | |
| PSHMPFSKAHWTPFE | 1761 | P27708 | |
| HFMTHQGIKPYRCSW | 411 | P51815 | |
| WYHDPACTTPVLKLM | 761 | Q9UIA9 | |
| SCSKVHFHLPYRWQM | 526 | Q7Z2W4 | |
| CVIWFFTPPSAHKYH | 511 | Q8IWB9 | |
| LPCHHYFHKPCVSIW | 611 | Q8NG27 | |
| THSGKTPYEFHEWPM | 281 | Q96NJ3 | |
| KSSMYTVGAPHTWPH | 166 | O14777 |